메뉴 건너뛰기




Volumn 92, Issue 1, 2008, Pages 143-159

Anticoagulation: Stroke Prevention in Patients with Atrial Fibrillation

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHENYTOIN; PLACEBO; PREDNISONE; TAMOXIFEN; THYROID HORMONE; WARFARIN;

EID: 36448971618     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2007.08.007     Document Type: Review
Times cited : (11)

References (38)
  • 1
    • 0023625745 scopus 로고
    • Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study
    • Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 147 (1987) 1561-1564
    • (1987) Arch Intern Med , vol.147 , pp. 1561-1564
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 2
    • 0026543430 scopus 로고
    • Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk
    • Stroke Prevention in Atrial Fibrillation Investigators
    • Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 116 (1992) 1-5
    • (1992) Ann Intern Med , vol.116 , pp. 1-5
  • 3
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials
    • Atrial Fibrillation Investigators
    • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457
  • 4
    • 33746833635 scopus 로고    scopus 로고
    • ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation)
    • Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 48 (2006) 854-906
    • (2006) J Am Coll Cardiol , vol.48 , pp. 854-906
    • Fuster, V.1    Ryden, L.E.2    Cannom, D.S.3
  • 5
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: results from a national registry of atrial fibrillation
    • Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from a national registry of atrial fibrillation. JAMA 285 (2001) 2864-2870
    • (2001) JAMA , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3
  • 6
    • 0042422040 scopus 로고    scopus 로고
    • A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study
    • Wang T.J., Massaro J.M., Levy D., et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290 (2003) 1049-1056
    • (2003) JAMA , vol.290 , pp. 1049-1056
    • Wang, T.J.1    Massaro, J.M.2    Levy, D.3
  • 7
    • 0024543543 scopus 로고
    • Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study
    • Petersen P., Boysen G., Godtfredsen J., et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1 (1989) 175-178
    • (1989) Lancet , vol.1 , pp. 175-178
    • Petersen, P.1    Boysen, G.2    Godtfredsen, J.3
  • 8
    • 0025914693 scopus 로고
    • Stroke Prevention in Atrial Fibrillation Study: Final Results
    • Stroke Prevention in Atrial Fibrillation Investigators
    • Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: Final Results. Circulation 84 (1991) 527-539
    • (1991) Circulation , vol.84 , pp. 527-539
  • 9
    • 0025241137 scopus 로고
    • The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
    • The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323 (1990) 1505-1511
    • (1990) N Engl J Med , vol.323 , pp. 1505-1511
  • 10
    • 0025814587 scopus 로고
    • Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
    • Connolly S., Laupacis A., Gent M., et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18 (1991) 349-355
    • (1991) J Am Coll Cardiol , vol.18 , pp. 349-355
    • Connolly, S.1    Laupacis, A.2    Gent, M.3
  • 11
    • 0026478818 scopus 로고
    • Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
    • Ezekowitz M., Bridgers S., James K., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 327 (1992) 1406-1412
    • (1992) N Engl J Med , vol.327 , pp. 1406-1412
    • Ezekowitz, M.1    Bridgers, S.2    James, K.3
  • 12
    • 0026048320 scopus 로고
    • Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials
    • Albers G.W., Sherman D.G., Gress D.R., et al. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol 30 (1991) 511-518
    • (1991) Ann Neurol , vol.30 , pp. 511-518
    • Albers, G.W.1    Sherman, D.G.2    Gress, D.R.3
  • 13
    • 36448950800 scopus 로고    scopus 로고
    • Anticoagulant coumadin tablets (warfarin sodium tablets, USP crystalline). In: Physicians Desk Reference. 61st edition, 2007; Thomson PDR at Montvale, NJ; pp 898-903.
  • 14
    • 0029741822 scopus 로고    scopus 로고
    • An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
    • Hylek E., Skates S., Sheehan M., et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335 (1996) 540-546
    • (1996) N Engl J Med , vol.335 , pp. 540-546
    • Hylek, E.1    Skates, S.2    Sheehan, M.3
  • 15
    • 0042387879 scopus 로고    scopus 로고
    • Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
    • Hylek E.M., Go A.S., Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349 (2003) 1019-1026
    • (2003) N Engl J Med , vol.349 , pp. 1019-1026
    • Hylek, E.M.1    Go, A.S.2    Chang, Y.3
  • 16
    • 19644400842 scopus 로고    scopus 로고
    • Advanced age anticoagulation intensity and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
    • Fang M.C., Chang Y., Hylek E.M., et al. Advanced age anticoagulation intensity and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 141 (2004) 745-752
    • (2004) Ann Intern Med , vol.141 , pp. 745-752
    • Fang, M.C.1    Chang, Y.2    Hylek, E.M.3
  • 17
    • 27444435844 scopus 로고    scopus 로고
    • Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation
    • NABOR Steering Committee
    • Waldo A.L., Becker R.C., Tapson V.F., et al., NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46 (2005) 1729-1736
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1729-1736
    • Waldo, A.L.1    Becker, R.C.2    Tapson, V.F.3
  • 18
    • 33746765044 scopus 로고    scopus 로고
    • Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study
    • Fang M.C., Go A.S., Hylek E.M., et al. Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study. J Am Geriatr Soc 54 (2006) 1231-1236
    • (2006) J Am Geriatr Soc , vol.54 , pp. 1231-1236
    • Fang, M.C.1    Go, A.S.2    Hylek, E.M.3
  • 19
    • 34547680113 scopus 로고    scopus 로고
    • Stroke prevention in elderly patients with atrial fibrillation
    • Garcia D., and Hylek E. Stroke prevention in elderly patients with atrial fibrillation. Lancet 370 (2007) 460-461
    • (2007) Lancet , vol.370 , pp. 460-461
    • Garcia, D.1    Hylek, E.2
  • 20
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis
    • Hart R., Benavente O., McBridge R., et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131 (1999) 492-501
    • (1999) Ann Intern Med , vol.131 , pp. 492-501
    • Hart, R.1    Benavente, O.2    McBridge, R.3
  • 21
    • 85025410072 scopus 로고
    • A differential effect of aspirin on prevention of stroke in atrial fibrillation
    • The SPAF Investigators
    • The SPAF Investigators. A differential effect of aspirin on prevention of stroke in atrial fibrillation. J Stroke Cerebrovasc Dis 3 (1993) 181-188
    • (1993) J Stroke Cerebrovasc Dis , vol.3 , pp. 181-188
  • 22
    • 0035964019 scopus 로고    scopus 로고
    • Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation
    • Cleland J.G.F., and Kaye G.C. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation. Br Med J 323 (2001) 233
    • (2001) Br Med J , vol.323 , pp. 233
    • Cleland, J.G.F.1    Kaye, G.C.2
  • 23
    • 9544248668 scopus 로고    scopus 로고
    • Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atria fibrillation: Stroke Prevention in Atrial Fibrillation III Randomized clinical trial
    • The SPAF Investigators
    • The SPAF Investigators. Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atria fibrillation: Stroke Prevention in Atrial Fibrillation III Randomized clinical trial. Lancet 348 (1996) 633-638
    • (1996) Lancet , vol.348 , pp. 633-638
  • 24
    • 0032557174 scopus 로고    scopus 로고
    • Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin
    • The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
    • The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin. JAMA 279 (1998) 1273-1277
    • (1998) JAMA , vol.279 , pp. 1273-1277
  • 25
    • 0037145826 scopus 로고    scopus 로고
    • All anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis
    • van Walraven C., Hart R.G., Singer D.E., et al. All anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA 288 (2002) 2441-2448
    • (2002) JAMA , vol.288 , pp. 2441-2448
    • van Walraven, C.1    Hart, R.G.2    Singer, D.E.3
  • 26
    • 0035837496 scopus 로고    scopus 로고
    • Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
    • Klein A.L., Grimm R.A., Murray R.D., et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 344 (2001) 1420-1441
    • (2001) N Engl J Med , vol.344 , pp. 1420-1441
    • Klein, A.L.1    Grimm, R.A.2    Murray, R.D.3
  • 27
    • 0034474717 scopus 로고    scopus 로고
    • Transesophageal echocardiography (TEE) in atrial fibrillation
    • Thamilarasan M., and Klein A.L. Transesophageal echocardiography (TEE) in atrial fibrillation. Cardiol Clin 18 (2000) 819-831
    • (2000) Cardiol Clin , vol.18 , pp. 819-831
    • Thamilarasan, M.1    Klein, A.L.2
  • 28
    • 0037028022 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
    • Wyse D.G., Waldo A.L., DiMarco J.P., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
    • (2002) N Engl J Med , vol.347 , pp. 1825-1833
    • Wyse, D.G.1    Waldo, A.L.2    DiMarco, J.P.3
  • 29
    • 19444384304 scopus 로고    scopus 로고
    • The occurrence and characteristics of stroke events in the AFFIRM study
    • Sherman D.G., Kim S.J., Boop B.S., et al. The occurrence and characteristics of stroke events in the AFFIRM study. Arch Intern Med 105 (2005) 1185-1191
    • (2005) Arch Intern Med , vol.105 , pp. 1185-1191
    • Sherman, D.G.1    Kim, S.J.2    Boop, B.S.3
  • 30
    • 0037028033 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
    • van Gelder I.C., Hagens V.E., Bosker H.A., et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347 (2002) 1834-1840
    • (2002) N Engl J Med , vol.347 , pp. 1834-1840
    • van Gelder, I.C.1    Hagens, V.E.2    Bosker, H.A.3
  • 31
    • 27144522548 scopus 로고    scopus 로고
    • Asymptomatic atrial fibrillation
    • Rho R.W., and Page R.L. Asymptomatic atrial fibrillation. Prog Cardiovasc Dis 48 (2005) 79-87
    • (2005) Prog Cardiovasc Dis , vol.48 , pp. 79-87
    • Rho, R.W.1    Page, R.L.2
  • 32
    • 0347228969 scopus 로고    scopus 로고
    • Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care
    • Israel C.W., Gronefeld G., Ehrlich J.R., et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43 (2004) 47-52
    • (2004) J Am Coll Cardiol , vol.43 , pp. 47-52
    • Israel, C.W.1    Gronefeld, G.2    Ehrlich, J.R.3
  • 33
    • 34447617533 scopus 로고    scopus 로고
    • New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device
    • Martinek M., Aichinger J., Nesser H.J., et al. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device. J Cardiovasc Electrophysiol 18 (2007) 818-823
    • (2007) J Cardiovasc Electrophysiol , vol.18 , pp. 818-823
    • Martinek, M.1    Aichinger, J.2    Nesser, H.J.3
  • 34
    • 36448941800 scopus 로고    scopus 로고
    • Guidelines for anticoagulation of atrial fibrillation: is it time for an update?
    • Raviele A. (Ed), Springer-Verlag Italia, Italy
    • Waldo A.L. Guidelines for anticoagulation of atrial fibrillation: is it time for an update?. In: Raviele A. (Ed). Cardiac arrhythmias 2005 (2006), Springer-Verlag Italia, Italy 169-176
    • (2006) Cardiac arrhythmias 2005 , pp. 169-176
    • Waldo, A.L.1
  • 35
    • 34249814933 scopus 로고    scopus 로고
    • HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS Task Force on Catheter and Surgical Ablation of Atrial Fibrillation)
    • Calkins H., Brugada J., Packer D.L., et al. HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS Task Force on Catheter and Surgical Ablation of Atrial Fibrillation). Heart Rhythm 4 (2007) 816-861
    • (2007) Heart Rhythm , vol.4 , pp. 816-861
    • Calkins, H.1    Brugada, J.2    Packer, D.L.3
  • 36
    • 34247523351 scopus 로고    scopus 로고
    • Venice Chart international consensus document on atrial fibrillation ablation
    • Natale A., Raviele A., Arentz T., et al. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 18 (2007) 560-580
    • (2007) J Cardiovasc Electrophysiol , vol.18 , pp. 560-580
    • Natale, A.1    Raviele, A.2    Arentz, T.3
  • 37
    • 0038300657 scopus 로고    scopus 로고
    • Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. Outcomes from a controlled, nonrandomized long term study
    • Pappone C., Rosario S., Augello G., et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. Outcomes from a controlled, nonrandomized long term study. J Am Coll Cardiol 42 (2003) 185-197
    • (2003) J Am Coll Cardiol , vol.42 , pp. 185-197
    • Pappone, C.1    Rosario, S.2    Augello, G.3
  • 38
    • 33747622292 scopus 로고    scopus 로고
    • Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation
    • Oral H., Chugh A., Ozaydin M., et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114 (2006) 759-765
    • (2006) Circulation , vol.114 , pp. 759-765
    • Oral, H.1    Chugh, A.2    Ozaydin, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.